TOG Review (RCOG Journal)
MRCOG Part 2
Postpartum Problems (Neonatal)
Newborn screening and the role of genomic testing
Key Statistics
- 9 — Conditions in UK newborn blood spot
- 6,000–8,000 — Estimated rare diseases
- 100,000 — Newborns – Generation study target
Don't-miss facts
-
UK Blood Spot = 9 conditions (CHT, CF, SCD, 6 IMDs); 6 IMDs can only be declined as a group
-
PPV varies 50–90% by condition; overall >99% of ~785,000 babies screened (2017–18) were "screen negative"
-
gNBS challenge = interpreting pathogenicity/penetrance/expressivity without a phenotype in an asymptomatic newborn
-
ICoNS criteria: include only if treatable/surveillance can start before age 5; never report VUS or carrier status
-
Generation Study: 100,000 newborns, 208 conditions, WGS of cord blood, 2024–2027, ~40 NHS trusts
-
Only pathogenic/likely pathogenic (ACGS) variants reported in GS; ~1% get a "condition-suspected" result
-
GS data pseudonymised in NGRL; never shared with insurers/marketers; retained to age 16 then re-consent sought
-
SMA = key example: early/pre-symptomatic gene therapy (replacing SMN1) transforms prognosis vs late treatment
Screening spectrum at a glance
UK Blood Spot: 9 conditions (TMS/other biomarkers) Generation Study: 208 conditions via WGS of cord blood
Abbreviation Key
- gNBS — genomic newborn sequencing
- MSUD — maple syrup urine disease
- WGS — whole-genome sequencing
- IVA — isovaleric acidaemia
- NGS — next-generation sequencing
- GA1 — glutaric aciduria type 1
- TMS — tandem mass spectrometry
- HCU — homocystinuria (pyridoxine unresponsive)
- PKU — phenylketonuria UK
- NSC — UK National Screening Committee
- CF — cystic fibrosis
- VUS — variant of uncertain significance
- SMA — spinal muscular atrophy
- ICoNS — Intl Consortium for Newborn Sequencing
- SCID — severe combined immunodeficiency disease
- ACGS — Association for Clinical Genomic Science
- SCD — sickle cell disease
- GS — the Generation Study
- CHT — congenital hypothyroidism
- NGRL — Natl Genomic Research Library
- IMD — inherited metabolic disease
- PPV — positive predictive value
- MCADD — medium-chain acyl-CoA dehydrogenase def.
Source: To M, Etheredge H, Pichini A et al. Newborn screening and the role of genomic testing: what obstetricians need to know. The Obstetrician & Gynaecologist 2025;27:278–285. doi:10.1111/tog.70009
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).